The Human Ovary and Future of Fertility Assessment in the Post-Genome Era

Int J Mol Sci. 2019 Aug 28;20(17):4209. doi: 10.3390/ijms20174209.

Abstract

Proteomics has opened up new avenues in the field of gynecology in the post-genome era, making it possible to meet patient needs more effectively and improve their care. This mini-review aims to reveal the scope of proteomic applications through an overview of the technique and its applications in assisted procreation. Some of the latest technologies in this field are described in order to better understand the perspectives of its clinical applications. Proteomics seems destined for a promising future in gynecology, more particularly in relation to the ovary. Nevertheless, we know that reproductive biology proteomics is still in its infancy and major technical and ethical challenges must first be overcome.

Keywords: biomarkers; fertility; mass spectrometry; oocyte competence; ovary.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Female
  • Fertilization in Vitro / methods
  • Humans
  • Infertility, Female / diagnosis
  • Infertility, Female / etiology*
  • Infertility, Female / therapy
  • Ovary / metabolism*
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / genetics
  • Polycystic Ovary Syndrome / metabolism*
  • Proteomics / methods*

Substances

  • Biomarkers